GetTopicDetailResponse(id=1fd11400953, topicName=Pegilodecakin, introduction=Pegilodecakin, content=null, image=null, comments=5, allHits=1124, url=https://h5.medsci.cn/topic?id=14009, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=94862, tagList=[TagDto(tagId=94862, tagName=Pegilodecakin)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1778424, encodeId=ffe01e78424d8, content=<a href='/topic/show?id=1fd11400953' target=_blank style='color:#2F92EE;'>#Pegilodecakin#</a>, objectTitle=JCO：Pegilodecakin+FOLFOX二線治療未能改善吉西他濱難治性轉(zhuǎn)移性胰腺癌的療效, objectType=article, longId=207010, objectId=0c9920e0107e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c9920e0107e, replyNumber=0, likeNumber=96, createdTime=2021-09-19, rootId=0, userName=徐巖, userId=f09239209229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c9920e0107e, moduleTitle=JCO：Pegilodecakin+FOLFOX二線治療未能改善吉西他濱難治性轉(zhuǎn)移性胰腺癌的療效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0c9920e0107e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778422, encodeId=30ce1e7842214, content=<a href='/topic/show?id=1fd11400953' target=_blank style='color:#2F92EE;'>#Pegilodecakin#</a>, objectTitle=禮來的聚乙二醇白細(xì)胞介素-10（pegilodecakin）在胰腺癌臨床試驗(yàn)中失敗, objectType=article, longId=181646, objectId=23b918164627, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23b918164627, replyNumber=0, likeNumber=94, createdTime=2019-10-31, rootId=0, userName=徐巖, userId=f09239209229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23b918164627, moduleTitle=禮來的聚乙二醇白細(xì)胞介素-10（pegilodecakin）在胰腺癌臨床試驗(yàn)中失敗, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=23b918164627)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778420, encodeId=b3991e78420a5, content=<a href='/topic/show?id=1fd11400953' target=_blank style='color:#2F92EE;'>#Pegilodecakin#</a>, objectTitle=Lancet oncol：Pegilodecakin聯(lián)合抗PD-1單克隆抗體是否可為晚期實(shí)體腫瘤提供新的治療機(jī)會(huì)？, objectType=article, longId=180124, objectId=a26018012453, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a26018012453, replyNumber=0, likeNumber=83, createdTime=2020-08-11, rootId=0, userName=徐巖, userId=f09239209229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a26018012453, moduleTitle=Lancet oncol：Pegilodecakin聯(lián)合抗PD-1單克隆抗體是否可為晚期實(shí)體腫瘤提供新的治療機(jī)會(huì)？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a26018012453)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778421, encodeId=f7ad1e7842154, content=<a href='/topic/show?id=1fd11400953' target=_blank style='color:#2F92EE;'>#Pegilodecakin#</a>, objectTitle=免疫療法pegilodecakin在胰腺癌中的III期研究未能達(dá)到總體生存的主要終點(diǎn), objectType=article, longId=181451, objectId=7dae1814517d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7dae1814517d, replyNumber=0, likeNumber=103, createdTime=2020-08-30, rootId=0, userName=徐巖, userId=f09239209229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7dae1814517d, moduleTitle=免疫療法pegilodecakin在胰腺癌中的III期研究未能達(dá)到總體生存的主要終點(diǎn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7dae1814517d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778423, encodeId=040a1e78423cf, content=<a href='/topic/show?id=1fd11400953' target=_blank style='color:#2F92EE;'>#Pegilodecakin#</a>, objectTitle=ASCO 2020年度胃腸道癌專題討論會(huì)：禮來的pegilodecakin未達(dá)到試驗(yàn)預(yù)期, objectType=article, longId=186805, objectId=c58218680512, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c58218680512, replyNumber=0, likeNumber=86, createdTime=2020-06-21, rootId=0, userName=徐巖, userId=f09239209229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c58218680512, moduleTitle=ASCO 2020年度胃腸道癌專題討論會(huì)：禮來的pegilodecakin未達(dá)到試驗(yàn)預(yù)期, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c58218680512)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
